Results

Total Results: 1,583 records

Showing results for "cancer".
Users also searched for: colon cancer screening

161. Anal Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/anal-cancer

162. Therapies for Clinically Localized Prostate Cancer: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-summary.pdf
     September 01, 2020 - Effects may not vary by patient or tumor factors. … one of the most frequently diagnosed cancers among U.S. men (191,930 new cases) and the second leading … cause of cancer death (33,330).1 In 90 percent of newly diagnosed cancers, the disease is confined … Effects may not vary by patient or tumor risk factors. … Age and tumor risk category may be important effect modifiers.

163. Colorectal-Cancer-Screening Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_executive.pdf
     February 01, 2012 - Adenoma—Benign tumor from epithelial tissue. … Stool DNA and occult blood testing for screen detection of colorectal neoplasia. … Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia … Detection of stool DNA mutations before and after treatment of colorectal neoplasia. … Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia

164. Data Points #15: Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/dcis-prognostic-tests/research
     September 13, 2012 - testing rates have increased over time for both ductal carcinoma in situ (DCIS) and early invasive cancers … Rates of BRCA genetic testing are very low (<2%) for both DCIS and early invasive breast cancers. … After tumor removal, some DCIS will recur or progress to invasive cancer. … For invasive breast cancer, specific markers of tumor aggressiveness are used to guide assessment of … We analyzed how testing varied by patient age, tumor size, and tumor grade--all factors known to increase

165. Comparative Effectiveness of Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults. (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
     February 01, 2012 - (Noffsinger AE Serrated polyps and colorectal cancer: new pathway to malignancy. … (Noffsinger AE Serrated polyps and colorectal cancer: new pathway to malignancy. … For cancer alone, there in fact is no need to weight since all cancers were included in the analysis … The footnote gives the weight for cancer plus HGD as 0.13; from Table 1, since there are 19 cancers … as 49% for n=39, it follows that 11/19 of cancers were positive and 19/39 cancer +HGD were positive

166. Data Points #10: Proton beam radiotherapy in the U.S. Medicare population: growth in use between 2006 and 2009 | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/radiotherapy-proton-beam/research
     May 07, 2012 - during the final portion of their trajectory, they diminish the risk of damage to tissue surrounding the tumor … beam radiotherapy has gained acceptance based on a theoretical advantage for the treatment of specific cancers … For example, proton beam radiotherapy is preferred for solid tumors in children because it minimizes … detrimental effects of radiation on developing structures surrounding the tumor and reduces the risk … Special documentation requirements for prostate cancer.

167. MEDLINE Searches (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
     March 01, 2009 - $ or tumor$ or malignan$ or carcino$ or neoplas$)).mp. … /ep, et 8 4 and 7 9 exp Breast Neoplasms/pc, eh 10 exp Breast Neoplasms/ge   A1-6 11 4 and … , urinary symptoms) • Adverse breast outcomes (biopsies) • Other malignancies (incidence, death) • … in situ: data from the Connecticut Tumor Registry. … Re: second cancers after adjuvant tamoxifen therapy for breast cancer.

168. Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/breast-cancer-imaging/technical-brief
     October 01, 2014 - Disposition of Comments Report Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer … literature found that, in general, uptake of tracers such as FDG in PET/CT scans is associated with tumor … An important potential advantage of FDG-PET/CT over conventional imaging for assessing tumor response … among metastatic breast cancer patients is that it provides functional information regarding tumor metabolism … research efforts should focus on identifying novel radiotracers and biomarkers that may clarify breast tumor

169. Disposition of Comments Report for Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_disposition-comments.pdf
     September 23, 2014 - in early stage small tumors. … Response Peer Reviewer 4 General Comments About Key Question 2 Most of data for staging of pancreatic cancers … However studies reporting outcomes in pancreatic cancer patients report that tumor size and locoregional … EUS is valuable in determining resectability of small tumors or tumors that are not visualized on CT … but EUS has clear advantage for small tumor and for pancreatic neuoendocrine tumors (Gastrointest

170. Executive Summary_Comparative Effectiveness Review No. 260: Nutrition as Prevention for Improved Cancer Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-executive-summary.pdf
     May 01, 2023 - Studies were predominately conducted in individuals with gastrointestinal and head and neck cancers, … predominately examined dietary supplements and nutrition support in gastrointestinal and head and neck cancers … Studies were predominately conducted in populations with gastrointestinal and head and neck cancers, … glutamine supplementation on the surgical outcome after pancreaticoduodenectomy for periampullary tumors … versus standard diet following McKeown minimally invasive esophagectomy in patients with esophageal malignancy

171. Executive Summary - Nutrition as Prevention for Improved Cancer Outcomes: Comparative Effectiveness Review No. 260 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-executive-summary_0.pdf
     May 01, 2023 - Studies were predominately conducted in individuals with gastrointestinal and head and neck cancers, … predominately examined dietary supplements and nutrition support in gastrointestinal and head and neck cancers … Studies were predominately conducted in populations with gastrointestinal and head and neck cancers, … glutamine supplementation on the surgical outcome after pancreaticoduodenectomy for periampullary tumors … versus standard diet following McKeown minimally invasive esophagectomy in patients with esophageal malignancy

172. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_executive.pdf
     May 01, 2010 - Layout 1 Background Head and neck cancers, specifically those arising in the oral cavity, larynx, … sinuses/nasal cavity, salivary glands, and occult primaries, account for approximately 3 to 5 percent of cancers … The main challenge in radiation therapy for cancer is to attain the highest probability of tumor control … Comparative Effectiveness Review Number 20 2 tumors for more than 50 years, it has been used mostly … short compared to some common cancers, such as breast or colon cancer.

173. Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
     February 01, 2012 - • For single HSCT for high-risk Ewings sarcoma family of tumors, high-risk relapsed Wilm’s tumor, … and risk of second cancers in patients who have undergone stem cell transplant for cancer. … neoplasms. … LYSATE-PULSED DENDRITIC VACCINE FOR HIGH-RISK SOLID TUMORS A Pilot Study of Tumor Cell Vaccine … for High-risk Solid Tumor Patients Following Stem Cell Transplantation; University of Michigan Cancer

174. CERs Report cover (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
     September 01, 2010 - and the most aggressive breast cancers. … Population- based estimates of the relation between breast cancer risk, tumor subtype, and family … Reactivation of Tumor Suppressor Genes in Breast Cancer by Dietary Supplements As. 2009. 178. 5F32AT004876 … Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature … /ep, et 10531 8 4 and 7 1164 9 exp breast neoplasms/pc, eh 7858 10 exp breast neoplasms/ge 18582

175. CER 174 Executive Summary: Imaging for the Pretreatment of Small Cell Lung Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/lung-cancer-staging_executive.pdf
     April 01, 2016 - percent of all lung cancers.3 Despite advances in diagnosis, treatment, and management of lung … Lung cancers are classified based on the size of the main tumor, whether it has locally invaded other … anatomic sites that harbor metabolically active malignant areas, FDG-PET helps distinguish malignant tumors … patient/tumor factor. … the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node

176. Future Research Needs Document (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
     October 25, 2010 - and the most aggressive breast cancers. … Population- based estimates of the relation between breast cancer risk, tumor subtype, and family history … Reactivation of Tumor Suppressor Genes in Breast Cancer by Dietary Supplements As. 2009. 178. 5F32AT004876 … Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature … /ep, et 10531 8 4 and 7 1164 9 exp breast neoplasms/pc, eh 7858 10 exp breast neoplasms/ge 18582

177. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_disposition-comments.pdf
     May 27, 2010 - treatment of prostate cancer, in addition to brain tumors, including those in children.” … a very large number of patients with similar tumors are randomized. … We have corrected the impression that xerostomia is common in patients with advanced cancers. … a very large number of patients with similar tumors are randomized. … We have corrected the impression that xerostomia is common in patients with advanced cancers.

178. Technical Brief Disposition of Comments Report for Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colon-cancer-gene-profiling_disposition-comments.pdf
     December 14, 2012 - Given what we know about traditional markers, particularly tumor grade, it is almost certain that patients … Response is generally reserved for metastatic disease where actual tumor measurements are possible. … #5 KI Background P 2 . . . patients with MSI-H tumors are excluded. Add the word tumors. … Public Agendia Background P.3 Tumor Heterogeneity (comment) Please note that the impact of tumor heterogeneity … issue of ASCO Post published a brief summary of data from this study that were presented at ASCO's GI Cancers

179. Menopause-Protocol-130612 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
     June 12, 2013 - “Colorectal Neoplasms” (mh) OR ((colorectal OR colon) AND (neoplasm* OR cancer OR carcinoma)) AND … OR ((ovarian OR breast OR colorectal OR colon OR endometrial) AND (cancer OR cancers OR carcinoma OR … #59 ‘colorectal neoplasms’/exp OR (colorectal OR ‘colon’/exp OR intestinal AND (‘neoplasm’/exp OR … ‘neoplasms’/exp OR ‘cancer’/exp OR ‘carcinoma’/exp)) AND [humans]/lim AND [english]/lim AND [embase] … /lim #60 #17 AND #59 #61 #56 AND #60 Ovarian Cancer #61 ‘ovarian’/exp AND (‘neoplasm’/exp OR

180. Menopausal Symptoms: Comparative Effectiveness Review of Therapies | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/menopause/research-protocol
     April 03, 2012 - “Colorectal Neoplasms” (mh) OR ((colorectal OR colon) AND (neoplasm* OR cancer OR carcinoma)) AND ( … OR ((ovarian OR breast OR colorectal OR colon OR endometrial) AND (cancer OR cancers OR carcinoma OR … #59 ‘colorectal neoplasms’/exp OR (colorectal OR ‘colon’/exp OR intestinal AND (‘neoplasm’/exp OR ‘ … neoplasms’/exp OR ‘cancer’/exp OR ‘carcinoma’/exp)) AND [humans]/lim AND [english]/lim AND [embase]/lim … #60 #17 AND #59 #61 #56 AND #60 Ovarian Cancer #61 ‘ovarian’/exp AND (‘neoplasm’/exp OR ‘neoplasms